This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

UKPDS 38 trial

Authoring team

The objective of the UKPDS-38 trial was to determine whether tight control of blood pressure prevents macrovascular and microvascular complications in patients with type 2 diabetes.

The trial randomly assigned patients to:

  • tight control of blood pressure aiming at <150/85 mmHg
  • less tight control aiming at <180/105 mmHg

The drugs used were ACE inhibitors or beta-blockers.

Reference:

  • 1) UK Prospective Diabetes Study Group (1998). Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ, 317, 703-713

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.